Building in-house PBPK modelling tools for oral drug administration from literature information
The interest in using physiologically-based pharmacokinetic (PBPK) models as a support to the drug development decision making process has rapidly increased in the last years. These kind of models are examples of the “bottom up” modelling strategy, which progressively integrates into a mechanistic f...
Main Authors: | Silvia Grandoni, Nicola Cesari, Giandomenico Brogin, Paola Puccini, Paolo Magni |
---|---|
Format: | Article |
Language: | English |
Published: |
International Association of Physical Chemists (IAPC)
2019-02-01
|
Series: | ADMET and DMPK |
Subjects: | |
Online Access: | http://pub.iapchem.org/ojs/index.php/admet/article/view/638 |
Similar Items
-
A Computational Workflow for Probabilistic Quantitative in Vitro to in Vivo Extrapolation
by: Kevin McNally, et al.
Published: (2018-05-01) -
Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
by: Paola Coppola, et al.
Published: (2021-06-01) -
Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
by: Lukas Kovar, et al.
Published: (2020-06-01) -
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen
by: Ioannis Loisios-Konstantinidis, et al.
Published: (2020-11-01) -
Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients
by: Nina Hanke, et al.
Published: (2019-04-01)